GTG 12.5% 0.5¢ genetic technologies limited

litigation

  1. 52 Posts.
    If the poster on ozestock is right and the company is Applied Biosciences (applera.com is the website), that loks like a sufficiently juicy company to sue - good revenue, but not so much that they can lose a lot on legal fees.

    GTG are probably attacking there new microarray assay they have just started marketing: the larger oligonucleotides they are using are likely to invove intron DNA.

    Just a guess!
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(12.5%)
Mkt cap ! $16.25M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $686 152.4K

Buyers (Bids)

No. Vol. Price($)
48 27991310 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 16102661 15
View Market Depth
Last trade - 10.06am 15/11/2019 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.